Mehta KA et al. |
Effect of formulation and process variables on porosity parameters and release rates from a multi unit erosion matrix of a poorly soluble drug. |
2000 |
J Control Release |
pmid:10640593
|
Ahmed T et al. |
Inhibition of allergic late airway responses by inhaled heparin-derived oligosaccharides. |
2000 |
J. Appl. Physiol. |
pmid:10797135
|
Thivierge M et al. |
IL-5 up-regulates cysteinyl leukotriene 1 receptor expression in HL-60 cells differentiated into eosinophils. |
2000 |
J. Immunol. |
pmid:11046055
|
Macfarlane AJ et al. |
Sputum cysteinyl leukotrienes increase 24 hours after allergen inhalation in atopic asthmatics. |
2000 |
Am. J. Respir. Crit. Care Med. |
pmid:10806153
|
Thodeti CK et al. |
Leukotriene D(4) triggers an association between gbetagamma subunits and phospholipase C-gamma1 in intestinal epithelial cells. |
2000 |
J. Biol. Chem. |
pmid:10734140
|
Underwood DC et al. |
SB 239063, a potent p38 MAP kinase inhibitor, reduces inflammatory cytokine production, airways eosinophil infiltration, and persistence. |
2000 |
J. Pharmacol. Exp. Ther. |
pmid:10734180
|
Ravasi S et al. |
A kinetic binding study to evaluate the pharmacological profile of a specific leukotriene C(4) binding site not coupled to contraction in human lung parenchyma. |
2000 |
Mol. Pharmacol. |
pmid:10825389
|
Ohd JF et al. |
Leukotrienes induce cell-survival signaling in intestinal epithelial cells. |
2000 |
Gastroenterology |
pmid:11040187
|
Nothacker HP et al. |
Molecular cloning and characterization of a second human cysteinyl leukotriene receptor: discovery of a subtype selective agonist. |
2000 |
Mol. Pharmacol. |
pmid:11093801
|
Bäck M et al. |
Antagonist resistant contractions of the porcine pulmonary artery by cysteinyl-leukotrienes. |
2000 |
Eur. J. Pharmacol. |
pmid:10936497
|
Kodani M et al. |
Intratracheal administration of anaphylatoxin C5a potentiates antigen-induced pulmonary reactions through the prolonged production of cysteinyl-leukotrienes. |
2000 |
Immunopharmacology |
pmid:10996024
|
Tran HS et al. |
The cardiovascular hemodynamics and leukotriene kinetics during prostacyclin and anti-prostacyclin antibody infusions in septic shock. |
2000 |
Shock |
pmid:10847636
|
Davis HM et al. |
Human granulocyte CD11b expression as a pharmacodynamic biomarker of inflammation. |
2000 |
J. Immunol. Methods |
pmid:10854607
|
Heise CE et al. |
Characterization of the human cysteinyl leukotriene 2 receptor. |
2000 |
J. Biol. Chem. |
pmid:10851239
|
Bäck M et al. |
Prostacyclin modulation of contractions of the human pulmonary artery by cysteinyl-leukotrienes. |
2000 |
Eur. J. Pharmacol. |
pmid:10936498
|
Mayatepek E et al. |
Defects in the synthesis of cysteinyl leukotrienes: a new group of inborn errors of metabolism. |
2000 |
J. Inherit. Metab. Dis. |
pmid:10896305
|
Lopes LR et al. |
Reduced inflammatory response in rats fed fat-rich diets: role of leukotrienes. |
2000 |
Life Sci. |
pmid:10896024
|
Mayatepek E et al. |
Analysis of leukotrienes in cerebrospinal fluid of a reference population and patients with inborn errors of metabolism: further evidence for a pathognomonic profile in LTC(4)-synthesis deficiency. |
2000 |
Clin. Chim. Acta |
pmid:10686285
|
Busse WW et al. |
Leukotriene pathway inhibitors in asthma and chronic obstructive pulmonary disease. |
1999 |
Clin. Exp. Allergy |
pmid:10421833
|
Han HJ et al. |
Leukotriene D4 inhibits Na+ uptake through cAMP and PLC pathways in primary cultured renal proximal tubular cells. |
1999 |
Kidney Blood Press. Res. |
pmid:10394108
|